Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)

BACKGROUND: Older patients with HER2-positive metastatic breast (HER2 + MBC) cancer are underrepresented in clinical trials. We aim to describe the treatment patterns and overall survival (OS) for older women receiving trastuzumab for HER2 + MBC. METHODS: Retrospective, whole-of-population cohort st...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniels, Benjamin, Kiely, Belinda E., Tang, Monica, Tervonen, Hanna, Pearson, Sallie-Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740010/
https://www.ncbi.nlm.nih.gov/pubmed/31510955
http://dx.doi.org/10.1186/s12885-019-6126-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6740010/
https://www.ncbi.nlm.nih.gov/pubmed/31510955
http://dx.doi.org/10.1186/s12885-019-6126-y

Ejemplares similares